Evaluation of neoadjuvant weekly nanoparticle albumin-bound paclitaxel for HER2-negative breast cancer

被引：1
|
作者：
Nagayama, A. [1 ]
Matsui, A. [1 ]
Tachibana, A. [2 ]
Suzuki, N. [3 ]
Hirata, M. [4 ]
Oishi, Y. [5 ]
Hamaguchi, Y. [6 ]
Murata, Y. [7 ]
Okamoto, Y. [8 ]
机构：
[1] Natl Hosp Org, Tokyo Med Ctr, Surg, Tokyo, Japan
[2] Mutual Aid Assoc Publ Sch Teachers, Kanto Cent Hosp, Breast Surg, Tokyo, Japan
[3] Omori Red Cross Hosp, Breast Surg, Tokyo, Japan
[4] JR Tokyo Gen Hosp, Breast Surg, Tokyo, Japan
[5] Nissan Tamagawa Hosp, Breast Surg, Tokyo, Japan
[6] Futakotamagawa Breast Clin, Breast Surg, Tokyo, Japan
[7] Natl Hosp Org, Tokyo Med Ctr, Pathol, Tokyo, Japan
[8] Toho Univ, Breast Surg, Med Ctr, Ohashi Hosp, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw365.75
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
296P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Overview of nanoparticle albumin-bound paclitaxel in metastatic breast cancer
    Strauch, Demetria Ileana
    Moreno-Aspitia, Alvaro
    BREAST CANCER MANAGEMENT, 2013, 2 (03) : 221 - 229
  • [22] Phase II study of neoadjuvant weekly albumin-bound paclitaxel for node-positive breast cancer
    Hattori, A.
    Hirano, A.
    Ogura, K.
    Inoue, H.
    Okubo, F.
    Miyamoto, R.
    Jibiki, N.
    Fujibayashi, M.
    Shimizu, T.
    BREAST, 2015, 24 : S92 - S92
  • [23] A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast Cancer
    Mirtsching, Barry
    Cosgriff, Thomas
    Harker, Graydon
    Keaton, Mark
    Chidiac, Tarek
    Min, Myo
    CLINICAL BREAST CANCER, 2011, 11 (02) : 121 - 128
  • [24] Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancer
    Shi, Wenjie
    Wan, Xinyu
    Wang, Ye
    He, Jinzhi
    Huang, Xiaofeng
    Xu, Yinggang
    Zhang, Weiwei
    Chen, Rui
    Wang, Lexin
    Zheng, Ran
    Ma, Lingjun
    Li, Xuan
    Xu, Lu
    Zha, Xiaoming
    Wang, Jue
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2023, 49
  • [25] Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis
    Zong, Yu
    Wu, Jiayi
    Shen, Kunwei
    ONCOTARGET, 2017, 8 (10) : 17360 - 17372
  • [26] A PILOT NEOADJUVANT STUDY OF SEQUENTIAL NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOLLOWED BY FEC IN ADVANCED BREAST CANCER
    Ohtani, S.
    Kochi, M.
    Abe, K.
    Sakata, Y.
    Hiraki, K.
    Fujiwara, Y.
    Iwamoto, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 127 - 127
  • [27] Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life
    Palumbo, Raffaella
    Sottotetti, Federico
    Trifiro, Giuseppe
    Piazza, Elena
    Ferzi, Antonella
    Gambaro, Anna
    Spinapolice, Elena Giulia
    Pozzi, Emma
    Tagliaferri, Barbara
    Teragni, Cristina
    Bernardo, Antonio
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2189 - 2199
  • [28] De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer
    Satoru Tanaka
    Nobuki Matsunami
    Hirotaka Morishima
    Naofumi Oda
    Tsutomu Takashima
    Satoru Noda
    Shinichiro Kashiwagi
    Yukie Tauchi
    Yuka Asano
    Kosei Kimura
    Hiroya Fujioka
    Risa Terasawa
    Kanako Kawaguchi
    Ayana Ikari
    Takashi Morimoto
    Shintaro Michishita
    Toshihiro Kobayashi
    Junna Sakane
    Toshikatsu Nitta
    Nayuko Sato
    Norihiro Hokimoto
    Yukihiro Nishida
    Mitsuhiko Iwamoto
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 1099 - 1104
  • [29] A phase II study of weekly nanoparticle albumin-bound paclitaxel combined with cisplatin in patients with metastatic breast cancer
    Wang, Biyun
    Hu, Xi-Chun
    Sun, Si
    Zhang, Jian
    Tang, Lichen
    Wang, Zhong Hua
    Wang, Lei Ping
    Lv, Fangfang
    Zhang, Qunling
    Zheng, Chunlei
    Jia, Zhen
    Lu, Yunhua
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer
    Tanaka, Satoru
    Matsunami, Nobuki
    Morishima, Hirotaka
    Oda, Naofumi
    Takashima, Tsutomu
    Noda, Satoru
    Kashiwagi, Shinichiro
    Tauchi, Yukie
    Asano, Yuka
    Kimura, Kosei
    Fujioka, Hiroya
    Terasawa, Risa
    Kawaguchi, Kanako
    Ikari, Ayana
    Morimoto, Takashi
    Michishita, Shintaro
    Kobayashi, Toshihiro
    Sakane, Junna
    Nitta, Toshikatsu
    Sato, Nayuko
    Hokimoto, Norihiro
    Nishida, Yukihiro
    Iwamoto, Mitsuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (06) : 1099 - 1104
12345